logo
Sign in

HNGZY Stock Price, Chart, Stats & News

Hangzhou Tigermed Consulting Co., Ltd
Save

Hangzhou Tigermed Consulting Co., Ltd (HNGZY) is a dividend-paying stock with a current dividend yield of 0.29% as of Aug 13, 2026. It pays $0.0130 per share over the trailing twelve months and distributes annually.

6.86B
Market cap
36.52x
Current P/E
16.78x
Forward P/E
0.29%
Dividend yield

Dividend safety

Strong

Dividend coverage looks healthy — HNGZY pays out about 11% of earnings.

See the safety analysis

HNGZY chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services.

Related lists

Similar securities

Based on sector and market capitalization

Report issue